Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.140.1%
QQQ
716.510.03%
BTC/USD
78465.100.2343%
DIA
524.880.15%
GLD
402.810.13%
TLT
81.680.06%

Niagen Bioscience Inc (NAGE) Stock Price, Quote, News & History

NAGENASDAQ
Trade with Public
Trade with Public
$3.05
-0.05-1.61%
At close: Sep 9, 5:00 PM EST
$3.05
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Niagen Bioscience (NAGE) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$3.11
Close
$3.05
Volume / Avg.
362.02K / 648.23K
Day Range
$3.03 - $3.11
52 Wk Range
2.87 - 10.52
Market Cap
$242.92M
P/E Ratio
16.05
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
8.31%
Days to Cover
5.36

Recent Niagen Bioscience Inc News

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ: FSLY) down 21.6%, and other stocks decline in pre-market trading.
Avi Kapoor

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED)

Niagen Bioscience reaffirms 2026 sales outlook after first-quarter revenue and profit rose alongside investments in injections and skincare.
Eva Mathew

Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting earnings estimate. Other stocks also down.
Avi Kapoor

Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Shares of Veeva Systems Inc (NYSE: VEEV) gained 11.3% in pre-market trading on upbeat Q4 results and FY27 guidance above estimates.
Avi Kapoor

Niagen Bioscience Rallies 18% After Hours: Here's Why

Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.
Mohd Haider
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
5.95M
Investing Cash Flow (TTM)
5.03M
Financing Cash Flow (TTM)
-4.71M
Free Cash Flow (TTM)
5.67M
Capital Expenditure (TTM)
-275.00K
Net Change in Cash (TTM)
6.27M

Analyst Trends and Forecast

1
Mar
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$176.92M
PE Ratio (TTM)
16.05
PE Ratio (FWD)
21.79
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.00
PB Ratio (TTM)
2.92
Earnings Yield % (TTM)
6.23%
Earnings Yield % (FWD)
4.59%
EV / EBITDA (TTM)
17.22
Price / EBITDA (TTM)
25.15
Price / Free Cash Flow (TTM)
45.55
Book Value / Share
$1.04

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$6.00K
Total Cash
$66.74M
Debt to Equity
0.03
Issuance of Debt (TTM)
-$6.00K
Repayment of Debt (TTM)
-$6.00K

Key Statistics

Open
$3.11
Close
$3.05
Volume / Avg.
362.02K / 648.23K
Day Range
$3.03 - $3.11
52 Wk Range
2.87 - 10.52
Market Cap
$242.92M
P/E Ratio
16.05
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
8.31%
Days to Cover
5.36

About

Sector
Consumer Staples
Industry
Personal Products
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Niagen Bioscience (NAGE) stock?

A

You can purchase shares of Niagen Bioscience (NASDAQ:NAGE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Niagen Bioscience (NAGE) competitors?

Q

What is the forecast, or price target, for Niagen Bioscience (NAGE) stock?

A

Niagen Bioscience has a consensus price target of $14.67.

Q

What is the current price for Niagen Bioscience (NAGE)?

A

The stock price for Niagen Bioscience (NASDAQ: NAGE) is $3.05 last updated September 9, 2026 at 4:00 PM EDT.

Q

Does Niagen Bioscience (NAGE) pay a dividend?

A

There are no upcoming dividends for Niagen Bioscience.

Q

When is Niagen Bioscience (NASDAQ:NAGE) reporting earnings?

A

Niagen Bioscience does not have any upcoming earnings scheduled.

Q

Is Niagen Bioscience (NAGE) going to split?

A

There is no upcoming split for Niagen Bioscience.

Q

What sector and industry does Niagen Bioscience (NAGE) operate in?

A

Niagen Bioscience is in the Consumer Staples sector and Personal Products industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved